<DOC>
	<DOCNO>NCT02944500</DOCNO>
	<brief_summary>The purpose protocol investigate effect treatment study drug Liraglutide , GLP-1 receptor agonist , center brain control appetite food intake .</brief_summary>
	<brief_title>Saxenda : Underlying Mechanisms Clinical Outcomes</brief_title>
	<detailed_description />
	<mesh_term>Liraglutide</mesh_term>
	<criteria>Obese : BMI &gt; 30 kg/m2 &gt; 27 kg/m2 comorbidities ( include limit insulin resistance , hypertension , dyslipidemia , cardiovascular disease , stroke , sleep apnea , gallbladder disease , hyperuricemia gout , osteoarthritis ) . 1 . Women breastfeed , pregnant , want become pregnant . 2 . Women use metal IUD 3 . Any change dosage hormonal contraceptive medication ( birth control pill , implanon ) . Subjects remain medication/ dose time entire study . 4 . Moderate ( creatinine clearance 3059 ml/min ) severe renal impairment ( creatinine clearance 30 ml/min ) endstage renal disease 5 . Moderate , severe hepatic impairment 6 . Hypersensitivity active substance excipients liraglutide 7 . History diabetic ketoacidosis 8 . Congestive heart failure 9 . EKG abnormality ( list ) 10 . Inflammatory condition like inflammatory bowel disease , Rheumatoid arthritis etc 11 . Gastroparesis 12 . Pancreatitis 13 . Gallstones may cause increase risk pancreatitis 14 . Alcohol consumption maximum quantity men 140g—210g per week . For woman , range 84g—140g per week drink consume two drink day men one woman . Alcohol cause increase risk pancreatitis hypoglycemia . 15 . Untreated thyroid disease like hypothyroidism hyperthyroidism 16 . Subjects take following medication : warfarin , steroid ( inhaled systemic due reduce hypoglycemic effect ) , subject hormone ( LHRH analogs etc ) . 17 . Subjects oral antidiabetic agent except metformin 18 . Personal family history MEN II medullary thyroid cancer 19 . Subjects type bioimplant activate mechanical , electronic , magnetic mean ( e.g . cochlear implant , pacemaker , neuron biostimulators , electronic infusion pump , etc . ) 20 . Subjects type metallic implant could potentially displace damaged MRI , aneurysm clip , metallic skull plate , surgical implant etc . metal contain tattoo 21 . Anxiety small space and/or claustrophobia 22 . Uncontrolled cardiac impairment , circulatory impairment , inability perspire ( poor thermoregulatory function ) 23 . Significant sensory motor impairment 24 . Epilepsy , particularly photosensitive epilepsy , may place individual high risk adverse event fMRI scan visual stimulation 25 . Subjects neurological psychological problem may interfere complicate testing ( e.g . presence titubation ) 26 . Body weight limitation MRI scan table ( 330lbs/150 Kg ) body dimension could difficult performance scan . 27 . Subjects adhere experimental protocol reason 28 . Anemia Hgb less 10 29 . Uncontrolled infectious disease ( e.g . HIV , hepatitis , chronic infection etc ) 30 . Any uncontrolled endocrine condition , e.g Cushing 's , Acromegaly , etc 31 . Any cancer lymphoma 32 . Eating disorder like anorexia , bulimia 33 . Severe hypertriglyceridemia ( triglyceride &gt; 500 mg/dl ) 34 . Weight loss surgery gastrectomy 35 . Any change medication affect brain function , e.g . antidepressant , antipsychotic , antianxiety , antiseizure medication , antihypertensive etc ( subject remain medication/ dose time entire study ) . 36 . Vegetarians food image present include numerous nonvegetarian item thus appeal high calorie food item . 37 . Suicidality , measure MSSI screen visit .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>100 Years</maximum_age>
	<verification_date>January 2017</verification_date>
	<keyword>Brain</keyword>
	<keyword>Liraglutide</keyword>
	<keyword>MRI</keyword>
</DOC>